Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).

× No keyword cloud information.

5 in total

1. Will pneumococci put quinolones in their place?

Authors: J M Legg; A J Bint
Journal: J Antimicrob Chemother Date: 1999-10 Impact factor: 5.790

2. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

Authors: D K Chen; A McGeer; J C de Azavedo; D E Low
Journal: N Engl J Med Date: 1999-07-22 Impact factor: 91.245

3. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.

Authors: R N Jones; M A Pfaller; G V Doern
Journal: Diagn Microbiol Infect Dis Date: 1998-10 Impact factor: 2.803

4. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.

Authors: G G Zhanel; J A Karlowsky; L Palatnick; L Vercaigne; D E Low; D J Hoban
Journal: Antimicrob Agents Chemother Date: 1999-10 Impact factor: 5.191

5. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study.

Authors: C Thornsberry; P T Ogilvie; H P Holley; D F Sahm
Journal: Antimicrob Agents Chemother Date: 1999-11 Impact factor: 5.191

5 in total

10 in total

1. Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America.

Authors: J A Karlowsky; L Nealy; D F Sahm; C Thornsberry; M E Jones
Journal: J Clin Microbiol Date: 2001-07 Impact factor: 5.948

2. Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.

Authors: Crystal N Johnson; William H Benjamin Jr; Stephen A Moser; Susan K Hollingshead; Xiaotian Zheng; Marilyn J Crain; Moon H Nahm; Ken B Waites
Journal: J Clin Microbiol Date: 2003-06 Impact factor: 5.948

3. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain.

Authors: Carmen Betriu; Iciar Rodríguez-Avial; Blas Ali Sánchez; María Gómez; Juan Alvarez; Juan J Picazo
Journal: Antimicrob Agents Chemother Date: 2002-03 Impact factor: 5.191

Review 4. New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors: Anna Maria Ferrara; Anna Maria Fietta
Journal: Drugs Aging Date: 2004 Impact factor: 3.923

5. Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study Team.

Authors: Ronald N Jones; Christopher M Rubino; Sujata M Bhavnani; Paul G Ambrose
Journal: Antimicrob Agents Chemother Date: 2003-01 Impact factor: 5.191

6. Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.

Authors: Po-Ren Hsueh; Lee-Jene Teng; Tsu-Lan Wu; Dine Yang; Wen-Kuei Huang; Jainn-Ming Shyr; Yin-Ching Chuang; Jen-Hsien Wan; Jing-Jou Yan; Jang-Jih Lu; Jiunn-Jong Wu; Wen-Chien Ko; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Chun-Ming Lee; Hsieh-Shong Leu; Cheng-Yi Liu; Kwen-Tay Luh
Journal: Antimicrob Agents Chemother Date: 2003-07 Impact factor: 5.191

Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).